Literature DB >> 33532616

Adiponectin, ALT and family history as critical markers for the development of type 2 diabetes in obese Japanese children.

Yuki Yasuda1, Nobuka Miyake1, Hisafumi Matsuoka1, Shigetaka Sugihara1.   

Abstract

Aims/Introduction: An association between the pathogenesis of type 2 diabetes mellitus (T2D) and that of metabolic syndrome (MS) in obese children has been suggested. We clarified the critical markers for the development of T2D in obese Japanese children.
Methods: One hundred and seven obese children who visited our outpatient clinic were enrolled in this study. The obese subjects were divided into 3 groups: Group A, T2D (n = 19); Group B, MS but not T2D (n = 19); and Group C: non-T2D, non-MS (n = 69). In all the subjects, a biochemical examination was performed and the serum adiponectin and leptin levels were measured. Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were measured using computed tomography images.
Results: Group A tended to have higher VAT values and VAT/SAT ratios and lower leptin and adiponectin levels, compared with Groups B and C. In Group A, the alanine aminotransferase (ALT) level was significantly higher and the aspartate aminotransferase (AST)/ALT ratio was significantly lower than in Group C. A receiver operating characteristic (ROC) analysis showed that the optimal cut-off point for adiponectin was 6.4 μg/mL (AUC = 0.859). The cut-off points for ALT, the AST/ALT ratio and VAT were 35 IU/L (AUC = 0.821), 0.85 (AUC = 0.794) and 78 cm2 (AUC = 0.713), respectively. Group A had a significantly higher frequency of a family history of T2D than Group B. Conclusions: Our study revealed that the adiponectin level, ALT level, AST/ALT ratio, VAT value and a family history of T2D may be critical characteristic markers for T2D among obese Japanese children.
© 2020 The Authors. Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd.

Entities:  

Keywords:  adiponectin; metabolic syndrome; type 2 diabetes mellitus

Year:  2020        PMID: 33532616      PMCID: PMC7831204          DOI: 10.1002/edm2.178

Source DB:  PubMed          Journal:  Endocrinol Diabetes Metab        ISSN: 2398-9238


  23 in total

1.  Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children.

Authors:  Yohei Ogawa; Toru Kikuchi; Keisuke Nagasaki; Makoto Hiura; Yukie Tanaka; Makoto Uchiyama
Journal:  Hypertens Res       Date:  2005-01       Impact factor: 3.872

2.  The metabolic syndrome in children and adolescents.

Authors:  Paul Zimmet; George Alberti; Francine Kaufman; Naoko Tajima; Martin Silink; Silva Arslanian; Gary Wong; Peter Bennett; Jonathan Shaw; Sonia Caprio
Journal:  Lancet       Date:  2007-06-23       Impact factor: 79.321

Review 3.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

4.  Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents.

Authors:  Ayako Ikezaki; Hiroshi Hosoda; Keiko Ito; Saika Iwama; Naoko Miura; Hisafumi Matsuoka; Chisato Kondo; Masayasu Kojima; Kenji Kangawa; Shigetaka Sugihara
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

5.  Determination of adiponectin in serum using a latex particle-enhanced turbidimetric immunoassay with an automated analyzer.

Authors:  Ayako Nishimura; Tokio Sawai
Journal:  Clin Chim Acta       Date:  2006-05-18       Impact factor: 3.786

Review 6.  Inflammation Markers in Type 2 Diabetes and the Metabolic Syndrome in the Pediatric Population.

Authors:  Thomas Reinehr; Christian Ludwig Roth
Journal:  Curr Diab Rep       Date:  2018-10-18       Impact factor: 4.810

7.  Usefulness of GPT for diagnosis of metabolic syndrome in obese Japanese children.

Authors:  Yuki Abe; Toru Kikuchi; Keisuke Nagasaki; Makoto Hiura; Yukie Tanaka; Yohei Ogawa; Makoto Uchiyama
Journal:  J Atheroscler Thromb       Date:  2009-12-22       Impact factor: 4.928

8.  Report of the committee on the classification and diagnostic criteria of diabetes mellitus.

Authors:  Yutaka Seino; Kishio Nanjo; Naoko Tajima; Takashi Kadowaki; Atsunori Kashiwagi; Eiichi Araki; Chikako Ito; Nobuya Inagaki; Yasuhiko Iwamoto; Masato Kasuga; Toshiaki Hanafusa; Masakazu Haneda; Kohjiro Ueki
Journal:  J Diabetes Investig       Date:  2010-10-19       Impact factor: 4.232

Review 9.  Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction.

Authors:  Arunkumar E Achari; Sushil K Jain
Journal:  Int J Mol Sci       Date:  2017-06-21       Impact factor: 5.923

10.  Leptin-adiponectin imbalance as a marker of metabolic syndrome among Chinese children and adolescents: The BCAMS study.

Authors:  Ge Li; Linxin Xu; Yanglu Zhao; Lujiao Li; Junling Fu; Qian Zhang; Naishi Li; Xinhua Xiao; Changhong Li; Jie Mi; Shan Gao; Ming Li
Journal:  PLoS One       Date:  2017-10-11       Impact factor: 3.240

View more
  1 in total

Review 1.  The Roles and Associated Mechanisms of Adipokines in Development of Metabolic Syndrome.

Authors:  Ji-Eun Kim; Jin-Sun Kim; Min-Jee Jo; Eunjung Cho; Shin-Young Ahn; Young-Joo Kwon; Gang-Jee Ko
Journal:  Molecules       Date:  2022-01-06       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.